Adjuvant chemotherapy with carmustine and cisplatin for patients with malignant gliomas
Data up to Jan 2025
Total Citations Per Year
Abstract
References (14)
Randomized Comparisons of Radiotherapy and Nitrosoureas for the Treatment of Malignant Glioma after Surgery
1980 • 1,625 citations
Prognostic Factors for Survival in Patients With Inoperable Lung Cancer<xref ref-type="fn" rid="FN2">2</xref>
1980 • 569 citations
Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarrazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report
1990 • 399 citations
Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma.
1983 • 394 citations
Necrosis as a prognostic criterion in malignant supratentorial, astrocytic gliomas
1983 • 282 citations
Human central nervous system distribution of cis-diamminedichloroplatinum and use as a radiosensitizer in malignant brain tumors.
1982 • 195 citations
Prediction of BCNU Pulmonary Toxicity in Patients with Malignant Gliomas
1980 • 189 citations
Delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: Clinicoanatomic correlations
1986 • 173 citations
Therapy of adult malignant brain tumors: what have the clinical trials taught us?
1986 • 145 citations
A Phase III comparison of BCNU, hydroxyurea, and radiation therapy to BCNU and radiation therapy for treatment of primary malignant gliomas
1979 • 102 citations
Phase II study of cisplatin in recurrent astrocytomas in adults: A southwest oncology group study
1983 • 68 citations
A pilot study of cis-diamminedichloroplatinum and radiation therapy in patients with high grade astrocytomas
1983 • 44 citations
Antitumor activity of cis-dichlorodiammineplatinum(II).
1979 • 36 citations
Phase II Trial of Intracarotid BCNU and Cisplatin in Primary Malignant Brain Tumors
1986 • 22 citations